EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases

Hye Jin Kim iD, Hee Jin Jung iD, Young Eun Kim, Daeun Jeong, Hyeon Seo Park iD, Hye Soo Park iD, Dongwan Kang iD, Yujin Park iD, Pusoon Chun iD, Hae Young Chung iD, Hyung Ryong Moon iD

Molecules · 2024

DOI: 10.3390/molecules29122887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Hye Jin Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Manufacturing Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republ…. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Agaricales, Antioxidants, Enzyme Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korean government (MIST), Basic Science Research Program Through the National Research Foundation (NRF) of Korea funded the Ministry of Education, Korean government (MIST).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on the fact that substances with a β-phenyl-α,β-unsaturated carbonyl (PUSC) motif confer strong tyrosinase inhibitory activity, benzylidene-3-methyl-2-thioxothiazolidin-4-one (BMTTZD) analogs 1–8 were prepared as potential tyrosinase inhibitors. Four analogs (1–3 and 5) inhibited mushroom tyrosinase strongly. Especially, analog 3 showed an inhibitory effect that was 220 and 22 times more powerful than kojic acid in the presence of l-tyrosine and l-dopa, respectively. A kinetic study utilizing mushroom tyrosinase showed that analogs 1 and 3 competitively inhibited tyrosinase, whereas analogs 2 and 5 inhibited tyrosinase in a mixed manner. A docking simulation study indicated that analogs 2 and 5 could bind to both the tyrosinase active and allosteric sites with high binding affinities. In cell-based experiments using B16F10 cells, analogs 1, 3, and 5 effectively inhibited melanin production; their anti-melanogenic effects were attributed to their ability to inhibit intracellular tyrosinase activity. Moreover, analogs 1, 3, and 5 inhibited in situ B16F10 cellular tyrosinase activity. In three antioxidant experiments, analogs 2 and 3 exhibited strong antioxidant efficacy, similar to that of the positive controls. These results suggest that the BMTTZD analogs are promising tyrosinase inhibitors for the treatment of hyperpigmentation-related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monophenol MonooxygenaseAgaricalesAntioxidantsEnzyme InhibitorsMolecular Docking SimulationMelaninsAnimalsMiceThiazolidinesCell Line, TumorKineticsMelanoma, ExperimentalBenzylidene CompoundsPyrones

Stichwörter der Autor:innen

BMTTZDdocking simulationmelanintyrosinaseβ-phenyl-α,β-unsaturated carbonyl

Substanzen

Monophenol MonooxygenaseAntioxidantsEnzyme InhibitorsMelaninsThiazolidineskojic acidBenzylidene CompoundsPyrones

Autor:innen und Institutionen

  • Department of Manufacturing Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea.
  • Department of Medicinal Chemistry, New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Gyeongnam, Republic of Korea.
  • Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.

ORCID-Profile: Hye Jin Kim, Hee Jin Jung, Hyeon Seo Park, Hye Soo Park, Dongwan Kang, Yujin Park, Pusoon Chun, Hae Young Chung, Hyung Ryong Moon

Förderung

  • National Research Foundation of Korea (NRF) grant funded by the Korean government (MIST)
  • Basic Science Research Program Through the National Research Foundation (NRF) of Korea funded the Ministry of Education
  • Korean government (MIST)
  • Ministry of Education

Zitieren

APA

Kim, H. J., Jung, H. J., Kim, Y. E., Jeong, D., Park, H. S., Park, H. S., Kang, D., Park, Y., Chun, P., Chung, H. Y., & Moon, H. R. (2024). Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases. Molecules. https://doi.org/10.3390/molecules29122887

Vancouver

Kim HJ, Jung HJ, Kim YE, Jeong D, Park HS, Park HS, et al. Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases. Molecules. 2024. doi:10.3390/molecules29122887

BibTeX
@article{Kim2024,
  author = {Kim, Hye Jin and Jung, Hee Jin and Kim, Young Eun and Jeong, Daeun and Park, Hyeon Seo and Park, Hye Soo and Kang, Dongwan and Park, Yujin and Chun, Pusoon and Chung, Hae Young and Moon, Hyung Ryong},
  title = {Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29122887}
}
Kostenlos starten →